Thymmune Therapeutics
Latest round
- Seed
Last raised
- Mar 2023
Total raised
- $7M
Investors
- 2
About Thymmune Therapeutics
a. Thymmune Therapeutics is a biotechnology company that is developing scalable therapies for aging and disease by utilizing its approach in iPSC-thymic cell manufacturing, which helps in generating off-the-shelf cells at scale. The company is developing a pipeline of therapies to treat immunodeficiencies, immunodeficiencies, transplant-related, and autoimmune disorders. Thymmune Therapeutics leverages its machine learning-enabled thymic engineering platform for the mass production of iPSC-derived thymic cells to restore immune function.
Who invested in Thymmune Therapeutics
2 investors across 1 round
See all investors in Thymmune Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 1, 2023
Amount
$7M
Investors
Questions about Thymmune Therapeutics
Who invested in Thymmune Therapeutics?
Thymmune Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Thymmune Therapeutics raised?
Thymmune Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Thymmune Therapeutics last raise money?
Thymmune Therapeutics's most recent round on record is a Seed, in Mar 2023.
What does Thymmune Therapeutics do?
Thymmune Therapeutics is a biotechnology company.
Where is Thymmune Therapeutics headquartered?
Thymmune Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Thymmune Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Thymmune Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Thymmune Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.